Featured Question

What is the development status of the different newer monoaminergic treatment options for major depressive disorder (MDD)?

See The Answer

Get the latest
science delivered
to your inbox

Answers in CME updates are
available in YOUR specialty.

Sign-up Now!

Featured Activities

10-21-2014

Latest Advances and Practical Considerations for the Management of Psoriasis

Course Director
Alan Menter, MD
Baylor University Medical Center
Baylor Psoriasis Research Center
University of Texas Southwestern Medical Center
Dallas, Texas

10-17-2014

Challenging Cases in Advanced Prostate Cancer: Expert Guidance on Selection and Sequencing of the Latest Therapies

Course Director
Oliver Sartor, MD
Tulane Cancer Center
Tulane University School of Medicine
New Orleans, Louisiana

10-02-2014

Latest Imaging Tools for Assessing the Disease Course of Patients With Multiple Sclerosis

Course Director
Matilde Inglese, MD, PhD
Icahn School of Medicine at
Mount Sinai
New York, New York

09-04-2014

Practical Considerations in the Management of Patients With Ulcerative Colitis

Course Director
William J. Sandborn, MD
University of California San Diego
La Jolla, California

09-02-2014

Current and Emerging Imaging Techniques in Multiple Sclerosis: Where Are We Now and Where Are We Going?

Course Director
Robert Naismith, MD
Washington University
School of Medicine
St. Louis, Missouri

08-04-2014

The Expanding Role of Biologic Therapies for Ulcerative Colitis: Assessing the State of the Science and Implications for Practice

Course Director
William J. Sandborn, MD
University of California San Diego
La Jolla, California

07-11-2014

Practical Considerations for the Management of Alzheimer’s Disease: Tools for Recognition of Early Disease and Nuances of Individualized Treatment Selection

Course Director
Anton P. Porsteinsson, MD
University of Rochester
School of Medicine and Dentistry
Rochester, New York

07-04-2014

Q&A: Assessing the Evolving Role of Angiogenesis-Targeting Agents in the Treatment of Gynecologic Cancers

Course Director
Maurie Markman, MD
Cancer Treatment Centers of America
Drexel University School of Medicine
Philadelphia, Pennsylvania

06-05-2014

Therapeutic Advances in Alzheimer’s Disease: Improving Adherence, Early Treatment Initiation, and Disease-Modifying Agents

Course Director
Gary W. Small, MD
David Geffen School of
Medicine at UCLA
Semel Institute for Neuroscience and Human Behavior
Stewart & Lynda Resnick Neuropsychiatric Hospital
Los Angeles, California

05-21-2014

Assessing the Evolving Therapeutic Landscape in Advanced Prostate Cancer: Where Do We Stand?

Course Director
Oliver Sartor, MD
Tulane Cancer Center
Tulane University School of Medicine
New Orleans, Louisiana